Tag:

Nasdaq: ONCT

Cancer Facts
Oncternal Therapeutics Presents New Preclinical Data

by admin June 11, 2022

by admin June 11, 2022

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical biopharmaceutical company focused on developing new tumor therapies, today from ROR1 target cells. Published preclinical data. The treatment program will be highlighted in…

HealCancer is the best newspaper and magazine website with tons of news articles and information about cancer and its facts and symptoms and research as well. This website is dedicated to spread awareness about the illness and help better understand and deal with it, visit our home page for more news .

newsletter

Editors' Picks

IASO Bio and Innovent Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Dolly Parton donates another $1M to aid pediatric COVID-19 research

Trial for cancer drug made in Oklahoma, called OK-1, set to begin

Latest Posts

Dolly Parton donates another $1M to aid pediatric COVID-19...

Trial for cancer drug made in Oklahoma, called OK-1,...

Rethink that drink: Alcohol ‘a factor in one in...

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Nasdaq: ONCT

Oncternal Therapeutics Presents New Preclinical Data

Editors' Picks

IASO Bio and Innovent Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Latest Posts